Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

Nuclera extends Series C funding to advance antibody engineering

Nuclera extends Series C funding to advance antibody engineering
p p Read More

Investment to accelerate development of full‑format antibody capabilities on eProtein Discovery system

January 14, 2026 News

Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies

Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
p p Read More

New manufacturing technologies aim to accelerate next-generation cell therapy development

January 13, 2026 News

Fabentech secures French approval for Ricimed antidote

Fabentech secures French approval for Ricimed antidote
p p Read More

Authorisation marks major step in European preparedness against ricin

January 12, 2026 News

Oxford Drug Design reports major in vivo milestone for novel cancer therapy

Oxford Drug Design reports major in vivo milestone for novel cancer therapy
p p Read More

Data shows potential route to overcoming resistance in aggressive colorectal tumours

January 12, 2026 News, Uncategorized

Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies

Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
p p Read More

Partnership will analyse m6A RNA modifications in patient samples to support development of STC‑15

January 8, 2026 News

Excellence adventure

Excellence adventure
p p Read More

The first Excellence in Healthcare Partnerships (EHP) Awards and Networking Evening is afoot

January 8, 2026 News

MHRA approves Nucala for eosinophilic COPD in adults on triple therapy

MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
p p Read More

New biologic option shown to reduce exacerbations and extend time to first flare

January 7, 2026 News

Bial launches new sublingual Parkinson’s treatment in UK

Bial launches new sublingual Parkinson’s treatment in UK
p p Read More

Sublingual apomorphine film offers rapid relief for OFF episodes

January 7, 2026 News

Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation

Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
p p Read More

First‑in‑class SK ion channel inhibitor enters next stage of clinical development

January 7, 2026 News

Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination

Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
p p Read More

Company aims to expand treatment options for relapsed or refractory multiple myeloma

January 6, 2026 News

Posts navigation

Posts pagination

« Previous 1 2 3 … 78 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy